Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving Psychological Health in People With Brain Injury

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHackensack Meridian Health

About this trial

The purpose of the study is to test two different training programs to find out which is better at helping people with a concussion or mild TBI (mTBI) improve their emotional health and well-being. Study participation is completely remote and will last approximately 8 months total, involving 4 assessment visits and 8 sessions of brain training via a secure video-conferencing platform. The 4 assessment visits (about 30-90 minutes each) include surveys and questionnaires about participant's emotional health. These assessment visits will take place before the training, immediately after the training, 3 months after training and 6 months after training. The 8 sessions of 1-on-1 training (about 60-90 minutes each) will be completed over the course of approximately 1 month.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Mild TBI

≥18 years old

≥6 months post-TBI

Elevated alexithymia and emotion dysregulation

Disqualifiers

Premorbid neurological disorder other than TBI

Degenerative neurologic condition

Active or uncontrolled major psychiatric disorder

Conditions that pose safety concern to self or others, such as suicide risk

Trial design

Design model

Parallel

Treatments tested in this trial

  • Program 1

    Behavioral

    Program 1 will teach participants how to recognize, label, and differentiate their emotions. The program will cover ways to reduce feeling "confused" or numb, and decrease the feelings of anger, stress and being overwhelmed.

  • Program 2

    Behavioral

    Program 2 will teach participants strategies to improve their overall brain health and functioning. It will also teach participants how to develop and work towards individualized short-term and long-term goals aimed at improving their quality of life.

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: Program 1Experimental treatment 1 intervention
Group B: Program 2Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Toronto Alexithymia Scale-20

his widely used alexithymia assessment (including the TBI population), is comprised of 3 factors: 1) ability to identify emotions); 2) ability to describe emotions; and 3) externally-oriented thinking. In addition to being a co-primary outcome measure, the TAS-20 scores will be used to determine eligibility (\>.5 SD above published means). It is a CDE and a PhenX toolkit measure has good psychometric properties, including good test-retest reliability. Range: Min/ Max = 20 to 100 Lower scores indicate less alexithymia (good); higher scores indicate greater alexithymia (bad)

Time frame
1) baseline 2) immediate post-treatment, 3) 3 months post-treatment; 4) 6- months post-treatment.
2

Difficulty with Emotion Regulation Scale (DERS; Co-Primary outcome)

This commonly used measure of emotion dysregulation, uses a 5-point Likert scale, participants rate the frequency they utilize self-regulation behaviors in response to general emotional distress. Items are summed to provide a Total Emotion Dysregulation score. The DERS has high internal consistency, test-retest reliability, and good construct validity.56 Will be used to evaluate emotion dysregulation and to determine eligibility (\>.5 SD above published means). Range: Min/ Max = 36 to 180. Lower scores indicate less dysregulation (good); higher scores indicate more dysregulation (bad)

Time frame
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

Secondary outcomes

1

Brief Resilience Scale (BRS)

Self-administered questionnaire with 6 items using a 5-point Likert-style scale to assess the ability to bounce back or recover from stress. Scores range from 6-30. The BRS is a recommended CDE in the PhenXToolkit and has been found to have good reliability and validity. Range: Min/ Max = 6 to 30. Lower scores indicate worse resilience; higher scores indicate better resilience

Time frame
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
2

Patient Health Questionnaire-9 (PHQ-9; depression)

This 9 item self-report depression assessment uses a 3-point Likert scale with established validity and reliability, including in the TBI population.64,65 Participants rate the frequency of specified problems during the past 2 weeks. Range: Min/ Max = 0 to 27 Lower scores indicate less depression; higher scores indicate higher depression

Time frame
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
3

PROMIS item banks for Anxiety

The PROMIS item bank (8a) for anxiety is 8 items and the Anger item bank (5a) includes 5 items. The Anxiety instrument measures self-reported fear (fearfulness, panic), anxious misery (worry, dread), hyperarousal (tension, nervousness, restlessness), and somatic symptoms related to arousal (racing heart, dizziness). All use a 5-point Likert scale, ranging from never to always. These are Common Data Elements (CDE) measures and have good psychometric properties. Range: Min/ Max = 8 to 40 Lower scores indicate less anxiety; higher scores indicate higher anxiety

Time frame
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
4

PROMIS item banks Anger

The PROMIS Anger instrument assesses self-reported angry mood (irritability, frustration), negative social cognitions (interpersonal sensitivity, envy, disagreeableness), and efforts to control anger. All use a 5-point Likert scale, ranging from never to always. These are Common Data Elements (CDE) measures and have good psychometric properties. Range: Min/ Max = 5 to 25 Lower scores indicate less anger; high scores indicate more anger

Time frame
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hackensack Meridian Health

Lead sponsor

United States Department of Defense

Collaborator